|
|
|
02-13-2017, 06:53 PM
|
#1 |
|
Infamous Member
How Do You Identify?:
Lesbian non-stone femme Preferred Pronoun?:
She, her Relationship Status:
Committed to being good to myself Join Date: Jun 2011
Location: West Coast
Posts: 8,258
Thanks: 39,306
Thanked 40,446 Times in 7,284 Posts
Rep Power: 21474858   |
NEWS RELEASES | RESEARCH | SOCIAL SCIENCE
February 13, 2017 New findings reveal health, aging experiences of LGBT older adults across nation In a first-of-its-kind study, researchers from the University of Washington’s School of Social Work have released new findings this month on the health and aging of lesbian, gay, bisexual and transgender older adults in the U.S. Approximately 2.7 million adults age 50 and older self-identify as lesbian, gay, bisexual or transgender. This number is expected to increase to more than five million by 2060, yet this population is critically understudied. UW researchers have been working to change that through the first longitudinal study of LGBT older adults, called Aging with Pride: National Health, Aging, Sexuality/Gender Study. “It’s important to understand the health and well-being of LGBT older adults so we can take steps to reduce health disparities,” said principal investigator Karen Fredriksen-Goldsen, professor and director of the UW’s Healthy Generations Hartford Center of Excellence. “This research highlights pathways to better understand health for all marginalized communities.” New findings from the longitudinal study, published in a 2017 supplement of The Gerontologist, will increase understanding of the challenges, strengths and needs of this growing yet underserved population. Funded by the National Institute on Aging, the research will help develop community-based interventions to improve the health and well-being of at-risk LGBT older adults. The team surveyed 2,450 adults aged 50 to 100, studying the impact of historical, environmental, psychological, social, behavioral and biological factors on LGBT adult health and well-being. The 10 articles that make up the supplement focuses on three themes: influence of life events; diversity and subgroup differences; and processes and mechanisms underlying health and quality of life. The findings reported in the supplement revealed that LGBT older adults are both resilient and at-risk, with higher rates of disability, cardiovascular disease, depression and social isolation. The findings documented how key life events ― including coming out, work and relationships ― are associated with health and quality of life. Articles examined factors such as race/ethnicity, partnership status, resiliency among HIV-positive gay and bisexual men, and transgender older adults with prior military service. The role of social networks, mental health, high-risk alcohol consumption and health care engagement were also studied. “The insights gleaned from this study of aging among LGBT older adults can deepen our understanding of the richness, diversity and resilience of lives across the life course,” Fredriksen-Goldsen said. “As we move forward in aging-related research, services and policies, it’s important to understand that these communities are diverse, and that unique groups face distinct challenges to their health.” ### For more information, contact Fredriksen-Goldsen at fredrikk@uw.edu or 206-543-5722. http://www.washington.edu/news/2017/...across-nation/
__________________
~Anya~  Democracy Dies in Darkness ~Washington Post "...I'm deeply concerned by recently adopted policies which punish children for their parents’ actions ... The thought that any State would seek to deter parents by inflicting such abuse on children is unconscionable." UN Human Rights commissioner |
|
|
| The Following User Says Thank You to *Anya* For This Useful Post: |
|
05-17-2017, 05:14 PM
|
#2 |
|
Infamous Member
How Do You Identify?:
Lesbian non-stone femme Preferred Pronoun?:
She, her Relationship Status:
Committed to being good to myself Join Date: Jun 2011
Location: West Coast
Posts: 8,258
Thanks: 39,306
Thanked 40,446 Times in 7,284 Posts
Rep Power: 21474858 |
Happy Nurses Day fellow RN's, LVN's, LPN's and CNA's!
__________________
~Anya~ Democracy Dies in Darkness ~Washington Post "...I'm deeply concerned by recently adopted policies which punish children for their parents’ actions ... The thought that any State would seek to deter parents by inflicting such abuse on children is unconscionable." UN Human Rights commissioner |
|
|
|
|
05-18-2017, 05:50 PM
|
#3 |
|
Infamous Member
How Do You Identify?:
Lesbian non-stone femme Preferred Pronoun?:
She, her Relationship Status:
Committed to being good to myself Join Date: Jun 2011
Location: West Coast
Posts: 8,258
Thanks: 39,306
Thanked 40,446 Times in 7,284 Posts
Rep Power: 21474858 |
Study: Stage III Colon cancer patients eating 2oz of nuts per week had 42% less recurrence
News Releases
Chance of Colon Cancer Recurrence Nearly Cut in Half in People Who Eat Nuts May 17, 2017 Contact Kelly Baldwin 571-483-1365 Kelly.Baldwin@asco.org ASCO Perspective “Basic healthy eating can often be overlooked during cancer treatment. This study shows that something as simple as eating tree nuts may make a difference in a patient’s long-term survival,” said ASCO President Daniel F. Hayes, MD, FACP, FASCO. “Nut consumption and a healthy diet are generally factors that clinicians and patients should perhaps pay attention to as they design the approach to treatment for colorectal cancer.” ALEXANDRIA, Va. – An observational study of 826 patients with stage III colon cancer showed that those who consumed two ounces or more of nuts per week had a 42% lower chance of cancer recurrence and 57% lower chance of death than those who did not eat nuts. A secondary analysis revealed the benefit of nut consumption was limited to tree nuts. Tree nuts include almonds, walnuts, hazelnuts, cashews, and pecans, among others. These findings will be presented at the upcoming 2017 ASCO Annual Meeting in Chicago. “Numerous studies in the fields of heart disease and diabetes have shown the benefits of nut consumption, and we felt that it was important to determine if these benefits could also apply to colorectal cancer patients,” said lead study author Temidayo Fadelu, MD, a clinical fellow in medicine at Dana Farber Cancer Institute. “Patients with advanced disease who benefit from chemotherapy frequently ask what else they can do to reduce their chances of recurrence or death, and our study is an important contribution to the idea that modifying diet and physical activity can be beneficial.” There was no associated reduction in cancer recurrence and death among patients who consumed peanuts or peanut butter. According to the authors, the reason may be that, being legumes, peanuts have a different metabolic composition than tree nuts. Peanuts are by far the most widely consumed nut in the U.S. Patients with stage III colon cancer have up to a 70% chance of surviving three years after treatment, which typically includes surgery and/or chemotherapy. While numerous prior studies have looked at diet as a potential cancer prevention tool, this is one of the first in colon cancer to look at the role of nut consumption and its influence on recurrence and mortality, according to the authors. About the Study The researchers analyzed a questionnaire from a CALGB clinical trial of patients with stage III colon cancer that began in 1999. The questionnaire, which was given after completion of chemotherapy, asked about dietary intake, including whether or not patients ate nuts and what types of nuts they consumed. Researchers were particularly interested in nut consumption because it has been linked to lower incidence of obesity, type 2 diabetes, and reduction in insulin resistance. These health conditions represent a state of excess energy and are each associated with a higher risk of recurrence and death from colon cancer. Key Findings The authors analyzed the associations between overall nut consumption, and just tree nut consumption, and the risk of cancer recurrence and death. Patients who consumed two or more ounces of all types of nuts per week (19% of all patients in the study) had a 42% lower chance of cancer recurrence and 57% lower chance of death than those patients who did not eat nuts after completion of their cancer treatment. The benefit of eating nuts was consistent across known factors that can influence cancer recurrence, including patient age, body mass index, gender, and common genomic changes in the tumor. When looking at just tree nut consumption, the chance of recurrence was 46% lower and the chance of death was 53% lower for those that ate at least two ounces per week, than for those who did not. Given that there was no significant reduction in cancer recurrence or death for those that ate peanuts or peanut butter, the authors conclude that in this study, the benefit is likely limited to tree nuts. More research is needed to understand the lack of association with peanuts. “It should be emphasized that the authors are not suggesting that eating nuts should be considered a substitute for standard chemotherapy and other treatments for colon cancer, which have dramatically improved survival,” said Dr. Hayes. “Rather, patients with colon cancer should be optimistic, and they should eat a healthy diet, including tree nuts, which may not only keep them healthier, but may also further decrease the chances of the cancer coming back.” Next Steps “We need to look at the potential positive impact of nut consumption on survival at other stages of colon cancer, particularly stage IV. Ultimately, we need to understand how nuts confer this protective effect, as well as possibly conduct a randomized, controlled clinical trial where diet recommendations are given at the start of the study to prove that tree nuts can reduce recurrence and death after treatment for colon cancer,” said Dr. Fadelu. This study was funded by the National Cancer Institute, of the National Institutes of Health, and Pfizer. View the full abstract. For your readers: Guide to Colorectal Cancer Food and Cancer Prevention View the disclosures for the 2017 ASCO Annual Meeting News Planning Team. Disclosures for Daniel F. Hayes, MD, FACP, FASCO: Stock and Other Ownership Interests with OncoImmune and InBiomotion; Honoria from Lilly; Research Funding with Janssen Research & Development (Inst.), AstraZeneca (Inst.), Puma Biotechnology (Inst.), Pfizer (Inst.), Lilly (Inst.), and Merrimack Pharmaceuticals/Parexel International Corporation (Inst.); Patents, Royalties and Other Intellectual Property with royalties from licensed technology to Janssen Diagnostics regarding circulating tumor cells; Travel, Accommodations, Expenses from Janssen Diagnostics. Disclosures for Bruce E. Johnson, MD, FASCO: Stock and Other Ownership Interests with KEW Group; Honoraria from Chugai Pharma and Merck; Consulting or Advisory Role with Amgen, AstraZeneca, Boehringer Ingelheim, Chugai Pharma, Clovis Oncology, Genentech, GlaxoSmithKline, KEW Group, Lilly, Merck, Novartis, and Transgene; Research Funding from Novartis (Inst.); Expert Testimony for Genentech. ATTRIBUTION TO THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING IS REQUESTED IN ALL COVERAGE. ### About ASCO: Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube. http://www.asco.org/about-asco/press...people-who-eat Related News Releases More Cancers Diagnosed at Early Stage Following Increase in Health Insurance Coverage May 17, 2017 Healthy Lifestyle After Colon Cancer Diagnosis Helps Patients Live Longer May 17, 2017 Oral Chemotherapy Extends Survival by More Than a Year in Biliary Tract Cancer May 17, 2017 HPV Vaccination May Reduce Oral HPV Infections – But Still Under-Utilized May 17, 2017 Targeted Therapy Can Delay Recurrence of Intermediate-Stage Lung Cancer May 17, 2017 Related Tags
__________________
~Anya~ Democracy Dies in Darkness ~Washington Post "...I'm deeply concerned by recently adopted policies which punish children for their parents’ actions ... The thought that any State would seek to deter parents by inflicting such abuse on children is unconscionable." UN Human Rights commissioner |
|
|
|
| The Following 4 Users Say Thank You to *Anya* For This Useful Post: |
|
05-18-2017, 06:19 PM
|
#4 | |
|
Member
How Do You Identify?:
Femme Join Date: May 2010
Location: Sharing my life with my granddaughter, family & friends. ツ
Posts: 16,141
Thanks: 29,547
Thanked 33,567 Times in 10,678 Posts
Rep Power: 21474868 |
Quote:
__________________
“The way someone treats you is not a reflection of your worth: It’s a reflection of their emotional capacity,” ~ Jillian Turecki.   |
|
|
|
|
| The Following User Says Thank You to Kätzchen For This Useful Post: |
|
09-23-2017, 12:17 AM
|
#5 |
|
Infamous Member
How Do You Identify?:
Lesbian non-stone femme Preferred Pronoun?:
She, her Relationship Status:
Committed to being good to myself Join Date: Jun 2011
Location: West Coast
Posts: 8,258
Thanks: 39,306
Thanked 40,446 Times in 7,284 Posts
Rep Power: 21474858 |
I am eager to look into more information about this. It could be the holy grail of treatment for this disease.
NewsHealth
HIV treatment breakthrough creates antibody that attacks 99 per cent of virus' strains Pathogen kills more than one million people each year around the world Tom Embury-Dennis @tomemburyd Friday 22 September 2017 19:30 BST Picture of a cell infected by HIV particles  An antibody that attacks 99 per cent of HIV strains has been developed by scientists for the first time. The “exciting breakthrough” could eventually lead to treatment or even prevent transmission of the virus, with trials on humans due to get underway in 2018. Experiments on 24 monkeys injected with HIV showed none developed the virus after first being given the new type of antibody, which attacks three critical parts of the disease. The human immune system struggles to deal with HIV due to its ability to mutate and change appearance. Our bodies eventually become overwhelmed by the number of different strains of the virus. But around one per cent of patients have the ability to develop “broadly neutralising antibodies”. These bind to structures on the surface of the pathogens known as “spikes”. Spikes barely change and are identical among different strains, making it possible for these special antibodies to attack different mutations of the virus. Now scientists have managed to combine three of these flexible antibodies into a powerful “tri-specific antibody”. Dr Gary Nabel, chief scientific officer at pharmaceutical company Sanofi and one of the report authors, told the BBC the results were “impressive”. “They are more potent and have greater breadth than any single naturally occurring antibody that's been discovered," he said. "We're getting 99 per cent coverage, and getting coverage at very low concentrations of the antibody.” An estimated 36.7 million people worldwide were living with HIV or AIDS at the end of 2015, with the majority in sub-Saharan Africa. Of these, only 60 per cent of people are aware they have it. In 2015 alone 1.1 million people died from the disease. The study was published in the journal Science, and is a collaboration between the US National Institutes of Health and Sanofi. The research included contributions from scientists at Harvard Medical School, The Scripps Research Institute and the Massachusetts Institute of Technology. http://www.independent.co.uk/news/he...-a7962276.html
__________________
~Anya~ Democracy Dies in Darkness ~Washington Post "...I'm deeply concerned by recently adopted policies which punish children for their parents’ actions ... The thought that any State would seek to deter parents by inflicting such abuse on children is unconscionable." UN Human Rights commissioner |
|
|
|
| The Following 4 Users Say Thank You to *Anya* For This Useful Post: |
|
09-29-2017, 02:01 AM
|
#6 |
|
Infamous Member
How Do You Identify?:
Lesbian non-stone femme Preferred Pronoun?:
She, her Relationship Status:
Committed to being good to myself Join Date: Jun 2011
Location: West Coast
Posts: 8,258
Thanks: 39,306
Thanked 40,446 Times in 7,284 Posts
Rep Power: 21474858 |
FDA OKs a blood sugar monitor that doesn't need fingerpricks
You just need to insert a tiny wire sensor under your skin. Mariella Moon, @mariella_moon 4h ago in Medicine  A fingerprick isn't just a fingerprick when you have to do it all the time to test your blood sugar levels. Thankfully, the Food and Drug Administration has approved the first continuous glucose monitoring system for adults that doesn't require you to draw blood several times a day. Abbott's FreeStyle Libre Flash Glucose Monitoring System works by inserting a tiny sensor wire below the surface of your skin. The wire needs 12 hours to start up, but once it's ready, you can simply pass a mobile reader over it to read your glucose levels. It even works for 10 days before you have to replace it. FDA's Donald St. Pierre explained that the agency has always been welcome to new technologies that can help people manage chronic conditions. "This system," he said, "allows people with diabetes to avoid the additional step of fingerstick calibration, which can sometimes be painful, but still provides necessary information for treating their diabetes -- with a wave of the mobile reader." Abbott already has a similar system available called the FreeStyle Libre Pro, but you need a doctor's help to use it and to activate the sensor wire under your skin. You don't need a doctor's help to determine if your sugar levels are too low, too high or just right with the Flash, but you have to be 18 and older to be able to get it. Coverage: Reuters In this article: abbott, freestylelibreflash, gear, GlucoseMonitoring, medicine https://www.engadget.com/2017/09/28/...e-libre-flash/
__________________
~Anya~ Democracy Dies in Darkness ~Washington Post "...I'm deeply concerned by recently adopted policies which punish children for their parents’ actions ... The thought that any State would seek to deter parents by inflicting such abuse on children is unconscionable." UN Human Rights commissioner |
|
|
|
|
11-09-2017, 04:43 PM
|
#7 |
|
Infamous Member
How Do You Identify?:
Lesbian non-stone femme Preferred Pronoun?:
She, her Relationship Status:
Committed to being good to myself Join Date: Jun 2011
Location: West Coast
Posts: 8,258
Thanks: 39,306
Thanked 40,446 Times in 7,284 Posts
Rep Power: 21474858 |
This is truly sad
Aaron Hernandez suffered from most severe CTE ever found in a person his age
By Adam Kilgore November 9, 2017 at 3:50 PM BOSTON — Aaron Hernandez suffered the most severe case of chronic traumatic encephalopathy ever discovered in a person his age, damage that would have significantly affected his decision-making, judgment and cognition, researchers at Boston University revealed at a medical conference Thursday. Ann McKee, the head of BU’s CTE Center, which has studied the disease caused by repetitive brain trauma for more than a decade, called Hernandez’s brain “one of the most significant contributions to our work” because of the brain’s pristine condition and the rare opportunity to study the disease in a 27-year-old. Hernandez, a former New England Patriots tight end, hanged himself with a bedsheet in April in a Massachusetts prison while serving a life sentence for the murder of his friend Odin Lloyd in 2013. In a diagnosis that linked one of football’s most notorious figures with the sport’s most significant health risk, doctors found Hernandez had Stage 3 CTE, which researchers had never seen in a brain younger than 46 years old, McKee said. Because the center has received few brains from people Hernandez’s age, McKee could not say whether Hernandez’s brain was representative of a 27-year-old who had played football as much as Hernandez. But she found the advanced stage of CTE alarming. “In this age group, he’s clearly at the severe end of the spectrum,” McKee said. “There is a concern that we’re seeing accelerated disease in young athletes. Whether or not that’s because they’re playing more aggressively or if they’re starting at younger ages, we don’t know. But we are seeing ravages of this disease, in this specific example, of a young person.” At Thursday’s conference, McKee flipped through slides comparing sections of Hernandez’s brain to a sample without CTE. Hernandez’s brain had dark spots associated with tau protein and shrunken, withered areas, compared to immaculate white of the sample. His brain had significant damage to the frontal lobe, which impacts a person’s ability to make decisions and moderate behavior. As some new slides appeared on the projectors, some physicians and conference attendees gasped. “We can’t take the pathology and explain the behavior,” McKee said. “But we can say collectively, in our collective experience, that individuals with CTE, and CTE of this severity, have difficulty with impulse control, decision-making, inhibition of impulses for aggression, emotional volatility, rage behaviors. We know that collectively.” McKee said Hernandez had a genetic marker that makes people vulnerable to certain brain diseases and could have contributed to how aggressively he developed CTE. “We know that that’s a risk factor for neurogenerative disease,” McKee said. “Whether or not that contributed in this case is speculative. It may explain some of his susceptibility to this disease.” The condition of Hernandez’s brain, pristine because of his age and the adept handling of medical examiners, could lead to future breakthroughs and better understanding of CTE. For example, researchers could better study the interaction of inflammation and tau pathology through the use of fluorescent stains. It gave researchers their best view yet of a marker associated with CTE. “We are able to understand this disease at the scientific level in a way that’s very rarely presented,” McKee said. “We’re very grateful to the family for making this donation. We’re hoping this will advance medical science in a very significant way. . . . This will really accelerate and advance our research going forward.” Medical examiners delivered Hernandez’s brain, weighing 1,573 grams, to BU’s labs in April. From the outside, it looked like a typical brain — no lesions, no bruises, no abnormalities. When researches sliced the brain into sections, they discovered startling damage. Ventricles were dilated, in response to the brain shrinking. Researchers determined Hernandez had lost brain tissue. Membranes that were supposed to be firm had grown “thin and gelatinous,” McKee said. There were abnormal, large holes in parts of Hernandez’s bran. The hippocampus, which plays a key role in memory, had shrunk. The fornix, which also contributes to memory function, had atrophied. The frontal lobe, which is responsible for problem-solving, judgment, impulse control and social behavior, had been pockmarked with tau protein. The amygdala, which produces emotional regulation, emotional behavior, fear and anxiety, had been severly affected. The temporal lobes, which process sights and sounds, showed significant damage. Together, they were “very unusual findings in an individual of this age,” McKee said. “We’ve never seen this in our 468 brains, except in individuals some 20 years older.” The physical damage inside Hernandez’s brain provides another layer to the catastrophic and tragic downfall of Hernandez, a gifted player who caught a touchdown pass from Tom Brady in the 2012 Super Bowl. Hernandez grew up a football star in Connecticut and fell in with a rough crowd at age 15, after his father died unexpectedly during a routine operation. He starred at Florida even as off-field trouble, in the form of drugs and violence, dogged him. The problems caused some teams to remove him from consideration in the NFL draft, and he lasted until the Patriots plucked him in the fourth round. Hernandez formed a dominating tandem with fellow 2010 draftee Rob Gronkowski and convinced the Patriots he had straightened out his life. The Patriots signed him to a seven-year, $40-million contract after the 2012 season. Months later, in the summer of 2013, Lloyd was murdered in the summer of 2013, his body found in a gravelly field a mile away from Hernandez’s mansion in North Attleboro. Hernandez’s estate filed a federal lawsuit against the Patriots in September, alleging the Patriots knew hits to the head could lead to brain damage and failed to protect him. A jury convicted Hernandez of the killing in 2015. Hernandez hanged himself in his cell just four days after a jury had acquitted him of the murders of Daniel de Abreu and Safiro Furtado, two strangers whom the state argued Hernandez killed in 2012 after an altercation at a Boston club. BU researchers say they have discovered CTE in more than 100 former NFL players, a handful of whom have committed suicide. The extent of damage in Hernandez’s brain represents another signpost in football’s ongoing concussion crisis. Thursday’s news conference coincided with the release of an NFL study consisting of video reviews of the 459 known concussions that occurred over the 2015 and 2016 seasons, from preseason games through the playoffs The NFL has attempted to make the sport safer for its players, through rule changes, policies designed to remove concussed players and technologic advances. But brain trauma occurs when a football player’s brain accelerates or decelerates after it hits another player or the turf, bashing the sides of the head, an action a helmet is defenseless against. “It happens inside the skull,” McKee said. “It’s an intrinsic component of football.” https://www.washingtonpost.com/sport...=.d7191a3753d1  Normal 27-year-old's brain and Aaron Hernandez's brain. (Boston University School of Medicine/Boston University School of Medicine)
__________________
~Anya~ Democracy Dies in Darkness ~Washington Post "...I'm deeply concerned by recently adopted policies which punish children for their parents’ actions ... The thought that any State would seek to deter parents by inflicting such abuse on children is unconscionable." UN Human Rights commissioner |
|
|
|
| The Following 2 Users Say Thank You to *Anya* For This Useful Post: |
 |
| Tags |
| health, healthcare |
|
|
Hybrid Mode
